Announcements Trials

Browse Landscape

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Gemcitabine × Tumor-Agnostic × Clear all

Phase

Status

Completed 51 Terminated 13 Unknown 8 Recruiting 7 Withdrawn 4 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 39 Genitourinary 14 Head & Neck 13 Breast 6 Thoracic 4 Lymphoid 3 Gynecologic 2 Tumor-Agnostic 1 Other solid neoplasm 1 Dermatologic 1 CNS 1

Conditions

Neoplasm Metastasis 1

Interventions

Standard of Care 4 Radiotherapy 4 Oxaliplatin 4 tislelizumab 3 trastuzumab deruxtecan 2 pembrolizumab 2 cemiplimab 2 Radiosurgery 2 Radiation 2 Paclitaxel 2 Data Collection 2 Capecitabine 2 130-nm albumin-bound paclitaxel 2 vedolizumab 1 trametinib 1 toripalimab 1 surufatinib 1 ivosidenib 1 disitamab vedotin 1 coenzyme Q10 1 blinatumomab 1 anlotinib 1 Whole Genome Sequencing 1 Ursodeoxycholic Acid 1 Ultrasonography 1 Tretinoin 1 Thymopentin 1 Surgical Procedures, Operative 1 Sequence Analysis, RNA 1 Respiratory Rate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07348107 2026-01-16

ATARI-PDAC

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Phase 1 Not yet recruiting

Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡